BeStock  
Stocks › Biotechnology › SEPN

Septerna SEPN

US equityMarket cap rank #2735Biotechnology
$38.61 −$0.59 (-1.51%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $38.61 0.00%
Open$38.72
Prev close$39.20
Day range$38.23 – $39.89
Volume374.3K
Market cap$1.84B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$18.88M-12.2% YoY
Operating profit-$27.23M-175.4% YoY
Net profit-$26.59M-425.3% YoY
Diluted EPS-$0.57-416.7% YoY
Free cash flow-$13.90M-108.2% YoY
Operating cash flow-$13.77M

Revenue, last 8 quarters

$212.0KDec '24$219.0KMar '25$119.0KJun '25$21.5MSep '25$24.1MDec '25$26.5MMar '26$26.7MJun '26$18.9MSep '26

Net profit, last 8 quarters

$-20.7MDec '24$-21.5MMar '25$-24.8MJun '25$8.2MSep '25$-10.7MDec '25$-8.6MMar '26$-13.0MJun '26$-26.6MSep '26

Diluted EPS by quarter

-0.64Dec '24-0.49Mar '25-0.56Jun '250.18Sep '25-0.24Dec '25-0.19Mar '26-0.29Jun '26-0.57Sep '26

Free cash flow by quarter

$-21.6MDec '24$-23.7MMar '25$-20.3MJun '25$168.8MSep '25$-15.1MDec '25$-26.5MMar '26$-22.2MJun '26$-13.9MSep '26

Annual revenue

$0.0FY22$151.0KFY23$1.1MFY24$46.0MFY25

Profitability & balance sheet

Operating margin-76.2%
Net margin-61.3%
Return on equity-14.4%
Return on assets-9.6%
Return on invested capital-16.5%
Current ratio4.84
Liabilities / assets30.9%
Cash & investments$478.60M
Total debt$19.48M
Net cash (debt)$459.12M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $18.88M $26.75M $26.52M $45.95M $24.12M
Total Operating Revenue $18.88M $26.75M $26.52M $45.95M $24.12M
Operating Expense $46.11M $43.58M $39.82M $126.75M $40.14M
Selling and Admin Expenses $9.55M $8.45M $10.29M $29.16M $8.28M
-General & Admin Expense $9.55M $8.45M $10.29M $29.16M $8.28M
Research & Development $36.56M $35.13M $29.54M $97.58M $31.86M
Operating Profit -$27.23M -$16.84M -$13.30M -$80.80M -$16.02M
Net Non-Operating Interest Income (Expense) $5.27M $4.78M $5.03M $19.53M $5.34M
Non-Operating Interest Income $5.27M $4.78M $5.03M $19.53M $5.34M
Other Income (Expense) -$12,000.00 – -$31,000.00 $12.40M -$41,000.00
Special Income (Charges) $0.00 – – $12.50M $0.00
-Gain on Sale of Property/Plant/Equipment $0.00 – – $12.50M $0.00
Other Non-Operating Income (Expenses) -$12,000.00 – -$31,000.00 -$100,000.00 -$41,000.00
Pretax Profit -$21.97M -$12.06M -$8.30M -$48.87M -$10.73M
Tax $4.62M $973,000.00 $337,000.00 $12,000.00 $12,000.00
Net Profit -$26.59M -$13.03M -$8.64M -$48.88M -$10.74M
Profit from Continuing Operations -$26.59M -$13.03M -$8.64M -$48.88M -$10.74M
Net Income to Parent Company -$26.59M -$13.03M -$8.64M -$48.88M -$10.74M
Net Income to Common Stockholders -$26.59M -$13.03M -$8.64M -$48.88M -$10.74M
Basic EPS -$0.57 -$0.29 -$0.19 -$1.10 -$0.24
Diluted EPS -$0.57 -$0.29 -$0.19 -$1.10 -$0.24

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $619.40M $566.74M $569.69M $596.19M $596.19M
Total Current Assets $507.35M $396.15M $368.06M $410.96M $410.96M
Cash and Cash Equivalents & Short-Term Investments $478.60M $372.32M $347.40M $391.09M $391.09M
-Cash and Cash Equivalents $167.12M $84.66M $71.61M $120.72M $120.72M
-Short Term Investments $311.48M $287.66M $275.80M $270.37M $270.37M
Receivables $21.88M $15.94M $14.29M $13.74M $13.74M
-Accounts Receivable $18.88M $12.16M $10.84M $10.36M $10.36M
-Accrued Interest Receivable $3.00M $3.78M $3.45M $3.38M $3.38M
Prepaid Assets $6.86M $7.76M $6.26M $4.98M $4.98M
Other Current Assets $13,000.00 $133,000.00 $110,000.00 $1.15M $1.15M
Total Non-Current Assets $112.06M $170.59M $201.63M $185.22M $185.22M
Net PPE $23.61M $24.26M $25.26M $25.93M $25.93M
-Gross PPE $29.20M $29.46M $30.03M $30.29M $30.29M
-Accumulated Depreciation -$5.59M -$5.20M -$4.77M -$4.35M -$4.35M
Investments and Advances $86.59M $144.19M $174.69M $157.57M $157.57M
-Available for Sale Securities $86.59M $144.19M $174.69M $157.57M $157.57M
Other Non-Current Assets $1.86M $2.14M $1.68M $1.72M $1.72M
Total Liabilities $191.48M $180.02M $191.23M $214.26M $214.26M
Total Current Liabilities $104.86M $79.32M $78.17M $86.93M $86.93M
Payables $11.34M $4.76M $7.46M $10.28M $10.28M
-Accounts Payable $6.96M $3.97M $7.46M $10.28M $10.28M
-Total Tax Payable $4.38M $788,000.00 – – –
Current Accrued Expenses $10.01M $9.02M $5.84M $6.09M $6.09M
Short-Term Debt and Capital Lease Obligation $2.51M $2.41M $2.31M $2.21M $2.21M
-Current Capital Lease Obligation $2.51M $2.41M $2.31M $2.21M $2.21M
Current Deferred Liabilities $75.96M $60.35M $59.76M $62.27M $62.27M
Other Current Liabilities $157,000.00 $95,000.00 $363,000.00 $148,000.00 $148,000.00
Total Non-Current Liabilities $86.61M $100.70M $113.07M $127.33M $127.33M
Long Term Debt and Capital Lease Obligation $19.48M $20.14M $20.78M $21.41M $21.41M
-Long Term Capital Lease Obligation $19.48M $20.14M $20.78M $21.41M $21.41M
Non-Current Deferred Liabilities $65.58M $80.04M $92.18M $105.92M $105.92M
Other Non-Current Liabilities $1.55M $521,000.00 $100,000.00 – –
Total Equity $427.93M $386.72M $378.46M $381.93M $381.93M
Stockholders' Equity $427.93M $386.72M $378.46M $381.93M $381.93M
Capital Stock $47,000.00 $46,000.00 $45,000.00 $45,000.00 $45,000.00
-Common Stock $47,000.00 $46,000.00 $45,000.00 $45,000.00 $45,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $645.44M $576.86M $554.87M $548.52M $548.52M
Retained Earnings -$215.51M -$188.92M -$175.89M -$167.25M -$167.25M
Gains/Losses Not Affecting Retained Earnings -$2.05M -$1.26M -$569,000.00 $617,000.00 $617,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$13.77M -$22.18M -$25.63M $110.19M -$14.99M
Net cash flow from continuing operations -$13.77M -$22.18M -$25.63M $110.19M -$14.99M
Net Income from Continuing Operations -$26.59M -$13.03M -$8.64M -$48.88M -$10.74M
Depreciation & Depletion & Amortization $394,000.00 $427,000.00 $421,000.00 $1.60M $401,000.00
Other Non-Cash Items $1.79M -$649,000.00 $569,000.00 $2.16M $569,000.00
Change in Working Capital $6.53M -$14.75M -$23.25M $162.78M -$6.99M
-Change in Receivables -$6.72M -$1.32M -$486,000.00 -$10.19M -$1.71M
-Change in Prepaid Assets $1.72M -$1.77M -$294,000.00 -$3.78M -$825,000.00
-Change in Payables and Accrued Expense $9.65M $463,000.00 -$5.84M $10.96M $10.41M
-Change in Other Current Assets $273,000.00 -$457,000.00 $43,000.00 -$554,000.00 -$316,000.00
-Change in Other Current Liabilities $1.03M $421,000.00 $100,000.00 – –
-Change In Other Working Capital $585,000.00 -$12.10M -$16.77M $166.34M -$14.55M
Net cash flow from investing $33.48M $18.41M -$23.82M -$229.35M -$185.30M
Net Cash Flow from Continuing Investing Activities $33.48M $18.41M -$23.82M -$229.35M -$185.30M
Net PPE Purchase and Sale -$127,000.00 $0.00 -$832,000.00 -$518,000.00 -$65,000.00
Net Investment Purchase and Sale $33.61M $18.41M -$22.99M -$241.33M -$185.24M
Financing Cash Flow $62.75M $16.82M $333,000.00 $1.69M $1.02M
Net Cash Flow from Continuing Financing Activities $62.75M $16.82M $333,000.00 $1.69M $1.02M
Net Common Stock Issuance $61.01M – – -$1,000.00 $0.00
Proceeds from Stock Option Exercised $1.74M $3.04M $333,000.00 $1.69M $1.02M
Ending Cash Balance $168.03M $85.57M $72.51M $121.63M $121.63M
Net Change in Cash $82.46M $13.06M -$49.12M -$117.47M -$199.27M
Beginning Cash Balance $85.57M $72.51M $121.63M $239.10M $320.89M
Free Cash Flow -$13.90M -$22.18M -$26.47M $109.67M -$15.05M
Gain/Loss from Continuing Operations – – – -$12.50M $0.00
Deferred Tax – – – $0.00 $0.00
Net Other Investing Changes – – – $12.50M $0.00
Net Preferred Stock Issuance – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on SEPN.

Sign in to join the discussion.

Scroll to Top